Edwards Lifesciences Corporation (FRA:EWL)
65.97
+0.51 (0.78%)
Last updated: Aug 14, 2025
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of €38.93 billion as of August 14, 2025. Its market cap has increased by 9.69% in one year.
Market Cap
38.93B
Enterprise Value
36.11B
Revenue
4.84B
Ranking
n/a
PE Ratio
11.02
Stock Price
€65.97
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from 984.05M to 38.93B, an increase of 3,856.02%. That is a compound annual growth rate of 15.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 38.93B | -7.69% |
Dec 31, 2024 | 42.17B | 0.80% |
Dec 29, 2023 | 41.84B | -3.07% |
Dec 30, 2022 | 43.16B | -39.31% |
Dec 31, 2021 | 71.12B | 53.00% |
Dec 31, 2020 | 46.48B | 7.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 270.19B |
Siemens Aktiengesellschaft | 179.63B |
Deutsche Telekom AG | 147.71B |
Allianz SE | 138.79B |
Siemens Energy AG | 77.82B |
Rheinmetall AG | 73.17B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 72.32B |
Deutsche Bank Aktiengesellschaft | 59.56B |